Stay updated with breaking news from 91307c10. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
United Therapeutics Co. (NASDAQ:UTHR – Get Rating) CEO Martine A. Rothblatt sold 8,000 shares of United Therapeutics stock in a transaction on Monday, May 1st. The stock was sold at an average price of $231.40, for a total transaction of $1,851,200.00. Following the transaction, the chief executive officer now directly owns 130 shares of the […]
United Therapeutics Co. (NASDAQ:UTHR – Get Rating) CEO Martine A. Rothblatt sold 8,000 shares of the company’s stock in a transaction dated Monday, May 1st. The stock was sold at an average price of $231.40, for a total value of $1,851,200.00. Following the completion of the transaction, the chief executive officer now directly owns 130 […]
United Therapeutics (NASDAQ:UTHR – Get Rating) had its price target cut by equities research analysts at Argus from $300.00 to $280.00 in a report issued on Friday, The Fly reports. Argus’ price target suggests a potential upside of 24.35% from the stock’s current price. Several other equities research analysts have also recently issued reports on […]
Tobam raised its stake in United Therapeutics Co. (NASDAQ:UTHR – Get Rating) by 163.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 109,284 shares of the biotechnology company’s stock after purchasing an additional 67,767 shares during the quarter. United Therapeutics accounts […]
United Therapeutics (NASDAQ:UTHR – Get Rating) had its price objective cut by Morgan Stanley from $320.00 to $316.00 in a research report released on Monday, The Fly reports. They currently have an overweight rating on the biotechnology company’s stock. Several other research analysts have also recently weighed in on UTHR. StockNews.com began coverage on shares […]